Clinical Trial Update: A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating fenofibrate to prevent kidney function decline in people with type 1 diabetes; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Alessandro Doria | Conditions: Diabetic Nephropathies | Phase 2 | Status: ACTIVE_NOT_RECRUITING